EMA Authorised: PecFent (fentanyl) — Gruenenthal GmbH

View source ↗

Summary

EMA authorised PecFent (fentanyl) by Gruenenthal GmbH for pain management, with therapeutic areas including Pain and Cancer (decision date 16 May 2024).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Drugs mentioned

• Pecfent (fentanyl citrate)

Snippet

Status: Authorised. Therapeutic area: Pain;Cancer. MAH: Gruenenthal GmbH. Decision date: 16/05/2024